Security Snapshot

NANOVIRICIDES INC - COM Institutional Ownership

CUSIP: 630087302

13F Institutional Holders and Ownership History from Q4 2023 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

1

Shares (Excl. Options)

105,000

Price

$0.91

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / COM
Price per share
$0.91
All holders as of 31 Mar 2026
Q1 2026
Total 13F shares
105,000
Total reported value
$95,771
Share change
0
Number of holders
1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Key facts

  • 630087302 - NANOVIRICIDES INC - COM is tracked under CUSIP 630087302.
  • 1 institution reported positions in Q1 2026.
  • Schedule 13D/13G significant owner rows are not currently available.

Change

  • Holder count moved from 4 to 1 between Q4 2025 and Q1 2026.
  • Reported value moved from $1,031,811 to $95,771.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 1 institution filings for Q1 2026.

Open SEC Evidence

Security key

630087302

Latest holder period

Q1 2026

13F holders

1

13D/G owners

0

CIK / CUSIP context first

As of 31 Mar 2026, 1 institutional investors reported holding 105,000 shares of NANOVIRICIDES INC - COM.

Institutional Holders of NANOVIRICIDES INC - COM across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 105,000 $95,771 $0.91 1
2025 Q4 913,107 $1,031,811 +$150,882 $1.13 4
2024 Q3 41,906 $62,859 $1.50 1
2024 Q2 200,658 $345,131 $1.72 2
2024 Q1 200,658 $232,763 -$632 $1.16 2
2023 Q4 201,203 $205,227 $1.02 2
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .